BehaveNet®
Clinical Capsule™

 
Join Our Mailing List

Email:

For Email Newsletters you can trust
Movies
Opinion
Facebook
Twitter

drug: galantamine


Clinical class....... nootropic
Action.................... reversible, competitive, acetyl cholinesterase inhibitor
CSA schedule none
DEA number none
Psychiatric uses NA
Active metabolites NA
Routes of administration oral
Associated with (substance-related)

disorders: none

Availability prescription

Also: galanthamine

U.S. Preparations:
Razadyne™ (Reminyl® Janssen) FDA approved:
6.22.2001 for treatment of mild to moderate dementia of the Alzheimer's type
U.S. Prescribing information
Dose: 4 mg. 8 mg. 12 mg.
Color:  off-white pink orange-brown
Shape: circular biconvex
Type: film-coated tablet
Imprint:

Janssen

G4 G8 G12

Razadyne™ ER (Reminyl® Janssen) FDA approved:
12.22.2004 for treatment of mild to moderate dementia of the Alzheimer's type
U.S. Prescribing information

Preparations Outside U.S.:
  • Nivalin 


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2012 BehaveNet®
Privacy | Medica Network Privacy Statement